Menu Search
Equities

XSpray Pharma AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
XSPRAY:STO

XSpray Pharma AB (publ)

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)27.95
  • Today's Change0.85 / 3.14%
  • Shares traded765.00
  • 1 Year change-11.35%
  • Beta0.0861
Data delayed at least 15 minutes, as of Feb 18 2026 08:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2025, cash reserves at XSpray Pharma AB (publ) fell by 54.49m. Cash Flow from Financing totalled 168.29m or -- of revenues. In addition the company used 193.16m for operations while cash used for investing totalled 29.19m.
Cash flow per share-4.28
Price/Cash flow per share--
Book value per share14.49
Tangible book value per share2.21
More ▼

Balance sheet in SEKView more

XSpray Pharma AB (publ) has a Debt to Total Capital ratio of 19.71%, a higher figure than the previous year's 4.35%.
Current ratio8.44
Quick ratio7.41
Total debt/total equity0.2454
Total debt/total capital0.1971
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.